Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Ichiro Tsujino"'
Autor:
Yuta Ohishi, Yoko Nakanishi, Yukari Hirotani, Atsuko Suzuki, Tomoyuki Tanino, Haruna Nishimaki‐Watanabe, Hiroko Kobayashi, Fumi Nozaki, Sumie Ohni, Xiaoyan Tang, Kentaro Hayashi, Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Noriaki Takahashi, Yasuhiro Gon, Shinobu Masuda
Publikováno v:
Thoracic Cancer, Vol 15, Iss 1, Pp 89-93 (2024)
Abstract The possibility of stratifying patients according to differences in ROS proto‐oncogene 1 (ROS1) fusion partners has been discussed. This study aimed to clarify the clinicopathological differences between two SDC4::ROS1 positive NSCLC cases
Externí odkaz:
https://doaj.org/article/0ee9eb7bb8d14098bd27a403b28e393c
Autor:
Sho Tanaka, Masaru Kushimoto, Tsukasa Nishizawa, Masahiro Takubo, Kazutaka Mitsuke, Jin Ikeda, Midori Fujishiro, Katsuhiko Ogawa, Ichiro Tsujino, Yutaka Suzuki, Masanori Abe
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 6, Iss 1, Pp 1-6 (2020)
Abstract Background The programmed cell death 1 (PD-1) inhibitor pembrolizumab is a promising agent for treatment of several different malignancies, but as with all immunotherapy there is a potential risk of immune-related adverse events. Adrenocorti
Externí odkaz:
https://doaj.org/article/3b86b70ab71847b89b4f1da7dc597394
Autor:
Masanori Abe, Katsuhiko Ogawa, Masahiro Takubo, Hisamitsu Ishihara, Midori Fujishiro, Yutaka Suzuki, Sho Tanaka, Jin Ikeda, Chikako Ichikawa, Ichiro Tsujino, Masaru Kushimoto
Publikováno v:
Therapeutics and Clinical Risk Management
The standard six-month tuberculosis (TB) treatment comprises an intensive phase lasting two months, followed by a continuation phase lasting four months. Meanwhile, the nine-month regimen, which has a prolonged continuation phase, is indicated for pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cbfdf0cd0e8ba57e31737f3272506d
http://europepmc.org/articles/PMC8164866
http://europepmc.org/articles/PMC8164866
Autor:
Masanori Abe, Yutaka Suzuki, Jin Ikeda, Sho Tanaka, Kazutaka Mitsuke, Katsuhiko Ogawa, Masaru Kushimoto, Ichiro Tsujino, Tsukasa Nishizawa, Masahiro Takubo, Midori Fujishiro
Publikováno v:
Clinical Diabetes and Endocrinology, Vol 6, Iss 1, Pp 1-6 (2020)
Clinical Diabetes and Endocrinology
Clinical Diabetes and Endocrinology
Background The programmed cell death 1 (PD-1) inhibitor pembrolizumab is a promising agent for treatment of several different malignancies, but as with all immunotherapy there is a potential risk of immune-related adverse events. Adrenocorticotropic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692fa9d681494ffe3f20f2d32be480a9
https://doaj.org/article/3b86b70ab71847b89b4f1da7dc597394
https://doaj.org/article/3b86b70ab71847b89b4f1da7dc597394
Publikováno v:
Journal of Clinical Biochemistry and Nutrition. 65:245-251
Calcitriol [1,25(OH)2D3] is usually investigated in studies on the preventive effect of activated vitamin D against interstitial pneumonia. Although cholecalciferol (vitamin D3) can be easily obtained in the diet and has a longer half-life than calci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eb6cde7ed939581848c2dc945ce99f4
https://doi.org/10.3164/jcbn.19-48
https://doi.org/10.3164/jcbn.19-48
Autor:
T. Tanino, Yasuhiro Gon, Yoko Nakanishi, Y. Ohishi, Tetsuo Shimizu, F. Nozaki, Yuko Iida, Y. Hirotani, Yoshiko Nakagawa, Xiaoyan Tang, S. Ohni, Ichiro Tsujino, Hiroko Kobayashi, Shinobu Masuda, Haruna Nishimaki
Publikováno v:
Journal of Thoracic Oncology. 16:S1094-S1095
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0fcf8405655f02409ca97d8d02a894a
https://doi.org/10.1016/j.jtho.2021.08.490
https://doi.org/10.1016/j.jtho.2021.08.490
Autor:
Yutaka Suzuki, Katsuhiko Ogawa, Masayoshi Souma, Yasuhito Nagata, Tsukasa Nishizawa, Shogo Akabame, Syu Hashimoto, Sadayuki Hasumi, Ichiro Tsujino
Publikováno v:
Journal of Nihon University Medical Association. 77:185-188
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5aca4e5743c8dc9614c2fd867311e1f7
https://doi.org/10.4264/numa.77.3_185
https://doi.org/10.4264/numa.77.3_185
Autor:
Shu Hashimoto, Mitsuhiko Moriyama, Yasuhiro Gon, Ogawa Masahiro, Takao Miura, Noriaki Takahashi, Fumio Kumasawa, Hiroshi Nakagawara, Ichiro Tsujino, Toshimi Takahashi, Shuichiro Maruoka, Takashi Ohki, Daisuke Endo
Publikováno v:
Journal of Infection and Chemotherapy. 22:486-489
A 69-year-old man with an 8-year history of hepatocellular carcinoma (HCC) was hospitalized for treatment of recurrent tumour. In 2010, the first transcatheter arterial chemoembolization (TACE) using miriplatin with agents (Lipiodol Ultra-Fluid) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4ea01ebba26a8a0468853ccd098f1ab
https://doi.org/10.1016/j.jiac.2016.01.003
https://doi.org/10.1016/j.jiac.2016.01.003
Autor:
Ichiro Tsujino, Yasushi Ouchi, Tetsuo Shimizu, Sumie Ohni, Norimichi Nemoto, Hisato Hiranuma, Noriaki Takahashi, Shu Hashimoto, Yukari Hirotani, Yoko Nakanishi
Publikováno v:
Medical Molecular Morphology. 49:98-109
Constitutive activation of extracellular signal-regulated kinase (ERK)1/2 pathway, that is activated by various stimuli including growth factors and oncogenic driver mutations, is observed in various cancers. However, the difference of the activated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f05cd65c297dd502394bd1b66b736d79
https://doi.org/10.1007/s00795-015-0130-3
https://doi.org/10.1007/s00795-015-0130-3
Autor:
Yoshiko Nakagawa, Tetsuo Shimizu, Ichiro Tsujino, Yoko Nakanishi, Shinobu Masuda, Shu Hashimoto, Noriaki Takahashi
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 13(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a0c1ddcccd78eec1124c61c2bfaf248
https://pubmed.ncbi.nlm.nih.gov/30244853
https://pubmed.ncbi.nlm.nih.gov/30244853